MA25347A1 - Composition du lypoglycan et methodes de traitement des infections d'origines parasites. - Google Patents

Composition du lypoglycan et methodes de traitement des infections d'origines parasites.

Info

Publication number
MA25347A1
MA25347A1 MA26327A MA26327A MA25347A1 MA 25347 A1 MA25347 A1 MA 25347A1 MA 26327 A MA26327 A MA 26327A MA 26327 A MA26327 A MA 26327A MA 25347 A1 MA25347 A1 MA 25347A1
Authority
MA
Morocco
Prior art keywords
composition
lypoglycan
methods
treating infections
origins
Prior art date
Application number
MA26327A
Other languages
English (en)
Inventor
H Semprevivo Lioyd
Original Assignee
Univ Massachusetts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Massachusetts filed Critical Univ Massachusetts
Publication of MA25347A1 publication Critical patent/MA25347A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
MA26327A 1999-03-12 2001-09-12 Composition du lypoglycan et methodes de traitement des infections d'origines parasites. MA25347A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12393199P 1999-03-12 1999-03-12

Publications (1)

Publication Number Publication Date
MA25347A1 true MA25347A1 (fr) 2001-12-31

Family

ID=22411778

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26327A MA25347A1 (fr) 1999-03-12 2001-09-12 Composition du lypoglycan et methodes de traitement des infections d'origines parasites.

Country Status (17)

Country Link
US (3) US6428793B1 (fr)
EP (1) EP1175226B1 (fr)
JP (1) JP2002538220A (fr)
AT (1) ATE439857T1 (fr)
AU (1) AU771373B2 (fr)
BR (1) BR0008949A (fr)
CA (1) CA2364507A1 (fr)
DE (1) DE60042776D1 (fr)
HU (1) HUP0200466A3 (fr)
MA (1) MA25347A1 (fr)
MX (1) MXPA01009206A (fr)
NO (1) NO20014411L (fr)
NZ (1) NZ514112A (fr)
PL (1) PL203789B1 (fr)
TR (3) TR200202078T2 (fr)
WO (1) WO2000053220A1 (fr)
ZA (1) ZA200107502B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
US7164520B2 (en) 2004-05-12 2007-01-16 Idc, Llc Packaging for an interferometric modulator
WO2006041613A2 (fr) * 2004-10-05 2006-04-20 Nanomega Medical Corporation Nanoparticules destinees au traitement de cellules hepatomes
EP2490707B1 (fr) * 2009-10-21 2016-07-27 ETH Zurich Utilité médicale des protéines liant les glycanes et des glycanes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598147B1 (fr) * 1986-04-30 1988-08-26 Pasteur Institut Immunogene isole de mollusques, son procede de preparation, reactifs de diagnostic des bilharzioses humaines, vaccins contre les schistosomiases et compositions immunisantes comprenant ledit immunogene.
FR2601021B2 (fr) * 1986-07-07 1988-11-18 Pasteur Institut Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant
US5212298A (en) 1989-08-16 1993-05-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5280113A (en) * 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5679347A (en) * 1992-12-10 1997-10-21 Brigham And Women's Hospital Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
US5541075A (en) * 1993-02-05 1996-07-30 Heska Corporation Carbohydrate-based vaccine and diagnostic reagent for trichinosis
BR9305075A (pt) * 1993-12-16 1995-08-08 Fundacao Oswaldo Cruz Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico
US6261788B1 (en) * 1998-09-21 2001-07-17 The Board Of Regents Of The University Of Oklahoma Diagnostic assays for infectious parasitic helminths

Also Published As

Publication number Publication date
PL350989A1 (en) 2003-02-24
ZA200107502B (en) 2003-02-26
CA2364507A1 (fr) 2000-09-14
US20020160021A1 (en) 2002-10-31
NO20014411D0 (no) 2001-09-11
PL203789B1 (pl) 2009-11-30
EP1175226B1 (fr) 2009-08-19
US7063848B2 (en) 2006-06-20
MXPA01009206A (es) 2003-07-14
DE60042776D1 (de) 2009-10-01
TR200202066T2 (tr) 2004-12-21
NO20014411L (no) 2001-11-09
EP1175226A4 (fr) 2005-01-05
HUP0200466A2 (en) 2002-06-29
NZ514112A (en) 2003-08-29
US7204983B2 (en) 2007-04-17
AU3625100A (en) 2000-09-28
TR200103231T2 (tr) 2002-03-21
TR200202078T2 (tr) 2002-11-21
US20060228382A1 (en) 2006-10-12
AU771373B2 (en) 2004-03-18
ATE439857T1 (de) 2009-09-15
HUP0200466A3 (en) 2006-11-28
BR0008949A (pt) 2002-09-24
WO2000053220A1 (fr) 2000-09-14
JP2002538220A (ja) 2002-11-12
EP1175226A1 (fr) 2002-01-30
US6428793B1 (en) 2002-08-06

Similar Documents

Publication Publication Date Title
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
AU2147992A (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
DE69425671D1 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
AU7877900A (en) Method of obtaining cellular immune responses from proteins
PT760649E (pt) Formulacoes a base de propionato de fluticasona
FR2737121B1 (fr) Nouvelles formulations galeniques du fenofibrate et leurs applications
BR9507400A (pt) Composições imunogénicas de polissacaridio streptococal grupo a e processos
PT692028E (pt) Farmacos baseados em papilomavirus
IT1179444B (it) Composizione farmaceutica a base di estratto solubile in piridina e di endotossina detossicata raffinata e suo impiego
DE69110877D1 (de) Idiotypen-impfung gegen b-zell-lymphoma.
IL161889A0 (en) Method for treating diseases with omega interferon
ES2188788T3 (es) Bi-heteroarilmetoxifenilalquil carboxilatos simetricos que inhiben la biosintesis de leucotrieno.
KR890701099A (ko) 기침 및 기관지 협착을 치료하기 위한 5-ht3 수용기 길항물질
HK1038310A1 (en) Compositions and methods for treating intracellular infections.
MA25347A1 (fr) Composition du lypoglycan et methodes de traitement des infections d'origines parasites.
BR9814432A (pt) Composições derivadas de mycobacterium vaccae e processo para seu uso
NO20023102L (no) Fremgangsmåte og formulering for behandling av residens mot anti-hypertensiver og relaterte tilstander
CA2225788A1 (fr) Agents therapeutiques pour maladies auto-immunes
EP1131338A4 (fr) Procede de production de proteine invasine hautement purifiee et utilisation de cette proteine
DE60045516D1 (de) Pflanzen lektine als mukosale adjuvantien
PT793666E (pt) Processo de sililacao
EP0328460A3 (fr) 1-(4-aminophényl)-2-hexaméthylèneiminopropanone, procédé de préparation et utilisation en thérapeutique